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BACKGROUND: Patients with autism have been often reported to have a smaller corpus callosum (CC) than control
subjects.
METHODS: We conducted a meta-analysis of the literature, analyzed the CC in 694 subjects of the Autism Brain
Imaging Data Exchange project, and performed computer simulations to study the effect of different analysis
strategies.
RESULTS: Our meta-analysis suggested a group difference in CC size; however, the studies were heavily
underpowered (20% power to detect Cohen’s d 5 .3). In contrast, we did not observe signiﬁcant differences in
the Autism Brain Imaging Data Exchange cohort, despite having achieved 99% power. However, we observed that
CC scaled nonlinearly with brain volume (BV): large brains had a proportionally smaller CC. Our simulations showed
that because of this nonlinearity, CC normalization could not control for eventual BV differences, but using BV as a
covariate in a linear model would. We also observed a weaker correlation of IQ and BV in cases compared with
control subjects. Our simulations showed that matching populations by IQ could then induce artifactual BV
differences.
CONCLUSIONS: The lack of statistical power in the previous literature prevents us from establishing the reality of the
claims of a smaller CC in autism, and our own analyses did not ﬁnd any. However, the nonlinear relationship between
CC and BV and the different correlation between BV and IQ in cases and control subjects may induce artifactual
differences. Overall, our results highlight the necessity for open data sharing to provide a more solid ground for the
discovery of neuroimaging biomarkers within the context of the wide human neuroanatomical diversity.
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Biohttp://dx.doi.org/10.1016/j.biopsych.2015.02.010Autism spectrum disorders (ASD) are pervasive developmental
disorders with qualitative impairments in social interaction and
communication, along with restricted, repetitive, and stereo-
typed patterns of behavior. Several cognitive studies have
suggested that difﬁculty integrating multiple sources of stim-
ulation may be a common characteristic of ASD, which has
led, for example, to the inﬂuential weak central coherence
hypothesis (1). The neural basis of these difﬁculties has been
hypothesized to be an imbalance between local and distant
connections: local overconnectivity and long-distance under-
connectivity (2,3). The connectivity hypothesis has been a
major subject of study and discussion in ASD research (4,5).
The corpus callosum (CC)—the largest commissure connecting
the left and right hemispheres—appeared then as a natural
candidate to look for evidence of connectivity abnormalities. The
CC exists exclusively within eutherian mammals (kangaroos and
other marsupials lack a CC) and has been suggested to play an
important role in the evolution of lateralization. The number of
callosal axons is disproportionally smaller in large-brain mammals6 & 2015 Society of Biological Psychiatry. This is an open access a
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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SEE COMMENTARY AR(like humans) compared with small-brain mammals (like mice). A
smaller number of callosal ﬁbers, and their increased length, could
hinder the formation of interhemispheric synchronous neuronal
populations, thus facilitating local recruitment and leading to
functional lateralization (6–8). The CC has been, as a conse-
quence, one of the most studied white matter tracts in ASD.
Numerous reports have indeed described signiﬁcantly smaller CC
among patients compared with control subjects, and a series of
studies have suggested a higher incidence of ASD within cases of
CC agenesis or callosotomy patients (9–11).
However, many of these analyses have relied on small cohorts
(30 patients, 30 control subjects), without statistical power to
ﬁnd even effect sizes as large as .5 standard deviations between
groups. Despite the lack of power, studies often report statisti-
cally signiﬁcant differences. A solution to the methodological
problems associated with small cohorts has been recently
proposed by the Autism Brain Imaging Data Exchange project
(Abide) (12). Large cohorts are difﬁcult to gather and analyze by
any single research group. Abide provides open access torticle under the CC BY-NC-ND license
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Psychiatrybehavioral and neuroimaging data for almost 600 patients and
600 age-, sex-, and IQ- matched control subjects from an
international consortium of 17 research groups. Abide provides
the research community with the statistical power necessary to
detect even small differences in case/control designs, and to use
more sophisticated analysis strategies, providing a wider per-
spective on neuroanatomical diversity.
Here, we ﬁrst present a review of studies of CC size differ-
ences in ASD. We observed a general lack of statistical power
(only 20% power to detect two-sided differences of .3 standard
deviations at .05 level of signiﬁcance), which contrasted with the
frequent report of signiﬁcant ﬁndings (9 out of 17 studies). Next,
we present our analysis of the diversity of the CC in Abide and
differences related to scanning sites, age, sex, brain size poly-
morphism, and diagnostic group. Even though previous studies
have reported diagnostic group differences as large as .3 to .7
standard deviations and despite having analyzed a number of
subjects comparable with the sum of all previously studied, we
did not ﬁnd signiﬁcant differences between patients with ASD
and control subjects. Finally, we discuss possible ways in which
analysis strategies, such as the normalization of CC size by total
brain volume (BV) or the matching of subjects by IQ scores,
could lead to artifactual differences in BV and CC size between
patients and control subjects.
METHODS AND MATERIALS
Meta-analysis
We included all studies from the recent review by Frazier and
Hardan (13) and searched PubMed (http://www.ncbi.nlm.nih.
gov/pubmed/) for additional studies reporting differences in
CC between patients with ASD and control subjects: (autismTable 1. Population in the Studies Included in the Meta-analys
Reference AgeASD 6 SD AgeCtrl 6 SD
Gaffney et al. 1987 (36) 11 6 5 12 6 5
Egaas et al. 1995 (37) 16 6 10 16 6 10
Piven et al. 1997 (38) 18 6 5 20 6 4 LF/H
Manes et al. 1999 (39) 14 6 7 12 6 5
Elia et al. 2000 (40) 11 6 4 11 6 3
Rice et al. 2005 (41) 12 6 4 13 6 4
Vidal et al. 2006 (42) 10 6 3 11 6 3
Boger-Mediggo et al. 2006 (43) 4 6 3 4 6 .5
Alexander 2007 (44) 16 6 7 16 6 6
Just et al. 2007 (3) 27 6 12 25 6 10
Hardan et al. 2009 (45) 11 6 1 11 6 1
Freitag et al. 2009 (46) 18 6 4 19 6 1
Keary 2009 (47) 20 6 10 19 6 9
Anderson et al. 2011 (48) 22 6 7 21 6 7
Hong et al. 2011 (49) 9 6 2 10 6 2
Frazier et al. 2012 (50) 11 (8–12)a 11 (7–13)a
Prigge et al. 2013 (51) 14 6 8 15 6 7 (HF/
Matching strategy: Relative: differences in BV were accounted by dividing
a covariate in a general linear model; IQ: differences in IQ were accounted
ASD, autism spectrum disorders; BV, total brain volume; CC, corpus call
high functioning; LF, low functioning; PIQ, performance IQ.
aAge range.
BiologicalOR PDD OR “pervasive developmental disorder”) AND “cor-
pus callosum”. Table 1 describes the cohort in the articles
meta-analyzed (see Figure S1 and Supplemental Materials in
Supplement 1 for further details on the inclusion procedure).
Analysis of Abide
We used FreeSurfer v5.1 (http://surfer.nmr.mgh.harvard.edu/)
to process the 1102 subjects in Abide (http://fcon_1000.
projects.nitrc.org/indi/abide) with T1-weighted magnetic reso-
nance imaging data available. We developed an open online
tool to visually control the accuracy of the segmentations
(http://siphonophore.org/corpuscallosum). Based on this qual-
ity control, we excluded 380 subjects, 331 of them because of
a mislabeled fornix that was included in the middle segment of
the CC (Figure 1; Figure S2 in Supplement 1). Not excluding
the subjects with a mislabeled fornix, however, did not change
our results. We only included subjects from 7.5 to 40 years old.
The ﬁnal sample consisted of 694 subjects: 328 patients (290
male subjects, 38 female subjects) and 366 control subjects
(304 male subjects, 62 female subjects). Full IQ (FIQ) was
available for 672 subjects and verbal IQ (VIQ) and performance
IQ (PIQ) for 538 subjects. Table 2 describes the groups of
subjects retained from each scanning site. Statistical analyses
were performed using JMP Pro 10.0.2 (http://www.jmp.com), R
(http://www.r-project.org/), iPython (http://ipython.org/), and
G*Power (http://gpower.hhu.de/) (see Supplemental Materials
in Supplement 1 for further details on the analysis).
Simulations
Simulations were written in Python to analyze the effect on
case/control comparisons produced by 1) normalization byis
IQ Level Matching Strategy
(LF/HF) NASD (F) NCtrl (F) Relative GLM IQ
LF/HF 13 (3) 35 (14) No No No
LF/HF 51 (6) 51 (6) No No No
F (PIQ . 70) 35 (6) 36 (16) No Yes No
LF 27 (5) 17 (6) Yes No Yes
LF 22 (0) 11 (0) No No No
HF/LF 12 (0) 8 (0) No Yes No
HF 24 (0) 26 (0) Yes Yes Yes
– 45 (7) 26 (8) Yes Yes No
HF (PIQ) 43 (–) 34 (–) No Yes Yes
HF 18 (1) 18 (3) Yes No Yes
HF 22 (0) 23 (0) Yes No Yes
HF 15 (2) 15 (2) No Yes Yes
HF 32 (2) 34 (2) No Yes Yes
HF/LF 53 (0) 39 (0) No No Yes
HF 18 (0) 16 (0) No Yes Yes
HF 23 (0) 23 (0) No Yes No
HF PIQ . 70) 68 (0) 47 (0) No Yes Yes
CC by BV; GLM: differences in BV were accounted by including BV as
for by matching groups by intelligence scores.
osum; Ctrl, control subjects; F, females; GLM, general linear model; HF,
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Figure 1. Segmentation of the corpus callosum. The corpus callosum
was segmented into ﬁve regions from genu to splenium: anterior, mid-
anterior, central, mid-posterior and posterior.
Table 2. Population of the Abide Project Retained for Analysis
Site Institution
NASD
Included/Total
NCtrl Included/
Total
Caltech California Institute of
Technology, USA
7/19 8/19
CMU Carnegie Mellon
University, USA
6/14 5/13
KKI Kennedy Krieger Institute,
USA
20/22 32/33
Leuven University of Leuven,
Belgium
27/29 28/35
MaxMun Ludwig Maximilian
University Munich,
Germany
11/24 22/33
NYU New York University
Langone Medical Center,
USA
54/79 75/105
OHSU Oregon Health and
Science University, USA
11/13 11/15
Olin Olin, Institute of Living at
Hartford Hospital, USA
16/20 14/16
Pitt University of Pittsburg,
School of Medicine, USA
30/30 27/27
SBL Social Brain Lab,
BCN NIC UMC Groningen
and Netherlands Institute
for Neurosciences,
Netherlands
7/15 8/15
SDSU San Diego State
University, USA
8/14 12/22
Stanford Stanford University, USA 8/20 5/20
Trinity Trinity Centre for Health
Sciences, Ireland
9/24 11/25
UCLA University of California,
Los Angeles, USA
32/62 35/47
UM University of Michigan,
USA
23/68 27/77
USM University of Utah, School
of Medicine, USA
42/58 26/43
Yale Yale Child Study Center,
USA
17/28 20/28
Total 328 366
ADOS, Autism Diagnostic Observation Schedule; AQ, Autism Quotient;
Responsiveness Scale.
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Psychiatrytotal BV, 2) covariation of total BV, and 3) IQ matching. The
code for these simulations has been made available as
iPython notebooks: http://siphonophore.org/corpuscallosum.RESULTS
Meta-analysis
On October 8, 2013, our PubMed query returned 183 articles,
among which 17 fulﬁlled our inclusion criteria. Combined,
these articles provided data on a total of 980 subjects, 521
patients with ASD, and 459 control subjects: 77 female
subjects, 903 male subjects; mean age 14.8 years old (data
are summarized in Table 3).
The ﬁxed and random effects meta-analyses provided an
estimated global effect size of .5 standard deviations, without
evidence of heterogeneity (p 5 .87, τ2 , .0001, H 5 1, I2 5
0%) (see forest plot in Figure 2). A standard test for publication
bias estimates the presence of a correlation between effectper Scanning Site
AgeASD
(Range)
AgeCtrl
(Range)
AQ
(ASD/Ctrl)
SRS
(ASD/Ctrl)
ADOS
(ASD/Ctrl)
26.3 (20–39) 25.2 (20–39) 19 (19/–)
27.5 (22–31) 31.2 (25–40) 14 (14/–)
9.9 (8–13) 10.2 (8–13) 22 (22/–)
17.4 (12–29) 17.7 (12–28) 29 (14/15) 64 (29/35)
21.2 (8–35) 25.4 (10–35) 6 (6/–)
14.7 (8–39) 16.3 (8–32) 149 (77/72) 79 (79/–)
11.1 (8–14) 9.9 (8–12) 13 (13/–)
17.4 (12–24) 16.9 (10–23) 20 (20/–)
18.9 (9–35) 18.9 (9–33) 26 (26/–)
30.7 (27–35) 32.9 (26–39) 27 (14/13) 8 (8/–)
15.2 (12–17) 14.3 (12–17) 13 (13/–)
9.6 (8–12) 11.2 (8–12) 19 (19/–)
18.2 (14–23) 17.6 (12–26) 24 (24/–)
13.3 (8–18) 12.9 (10–18) 61 (61/–)
12.8 (9–19) 14.8 (9–29)
22.0 (11–38) 22.9 (9–39) 100 (58/42) 90 (58/32)
13.1 (9–18) 12.9 (8–18) 52 (26/26) 1 (1/–)
16.6 (8–39) 17.0 (8–40) 56 365 415
ASD, autism spectrum disorders; Ctrl, control subjects; SRS, Social
urnal
Table 3. Meta-analysis: Mean CC Size, Effect Size, Signiﬁcance of the Difference, Statistical Power.
p Value Power to Detect
Reference NASD NCtrl Mean CCASD 6 SD (cm
2) Mean CCCtrl 6 SD (cm
2) Effect Size (Two-Sided) SD 5 .3 (Two-Sided)
Gaffney et al. 1987 (36) 13 35 5.89 6 1.04 6.24 6 1.37 2.27 .41 17.3%
Egaas et al. 1995 (37) 51 51 5.57 6 .99 5.89 6 .91 2.33 .097 32.3%
Piven et al. 1997 (38) 35 36 6.15 6 .83 6.40 6 .38 2.39 .11 24.1%
Manes et al. 1999 (39) 27 17 4.64 6 .99 5.71 6 .97 21.07 .0011 16.2%
Elia et al. 2000 (40) 22 11 5.26 6 1.00 5.41 6 .64 2.16 .67 12.7%
Rice et al. 2005 (41) 12 8 7.34 6 1.11 7.75 6 1.14 2.35 .45 9.3%
Vidal et al. 2006 (42) 24 26 6.06 6 1.15 6.68 6 .79 2.62 .033 17.9%
Boger-Megiddo et al. 2006 (43) 45 26 4.59 6 .67 4.99 6 .72 2.57 .022 24.1%
Alexander et al. 2007 (44) 43 34 7.87 6 1.99 9.32 6 .70 2.77 .012 25.2%
Just et al. 2007 (3) 18 18 6.40 6 .88 7.1 6 .88 2.78 .025 13.9%
Hardan et al. 2009 (45) 22 23 5.74 6 1.13 6.58 6 1.04 2.76 .014 16.2%
Freitag et al. 2009 (46) 15 15 6.22 6 .45 6.54 6 1.24 2.34 .36 12.2%
Keary et al. 2009 (47) 32 34 6.19 6 1.09 6.76 6 1.10 2.51 .040 22.4%
Anderson et al. 2011 (48) 53 39 6.54 6 1.20 7.05 6 .90 2.46 .031 29.6%
Hong et al. 2011 (49) 18 16 8.14 6 1.31 8.27 6 1.27 2.10 .78 13.3%
Frazier et al. 2012 (50) 23 2 6.30 6 1.11 6.78 6 1.08 2.43 .15 16.7%
Prigge et al. 2013 (51) 68 47 5.74 6 .91 6.24 6 .89 2.55 .0044 36.0%
The different values were scaled to provided measurements in cm2 (this scaling does not affect our meta-analysis, which was performed on
standardized mean differences).
ASD, autism spectrum disorders; CC, corpus callosum; Ctrl, control subjects.
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Psychiatrysize and standard error for each study (14). A correlation could
be detected if small studies were more likely to be published
when the effect size is large and then more likely to produce a
statistically signiﬁcant ﬁnding. Large studies, which approx-
imate better the true effect size, should then provide a
reference. The funnel plot (Figure 3) was symmetric, and we
did not ﬁnd a signiﬁcant correlation between the effect size
and the standard error of each study (p 5 .87, t 5 .169).
However, it is difﬁcult to establish whether there was a
publication bias or not using this method because there were
no really large studies in our sample: the largest statistical
power to detect a .3 standard deviation was 36% (statistical
power for each article is reported in Table 3). In general, the
mean achieved power (power to detect the reported effect
size) was 46.9%. A priori, the studies were very underpoweredBiologicalto detect a difference of .3 standard deviations (what is
commonly considered to be a small difference): 20% power.
Despite the general lack of power, however, 9 out of 17
studies reported signiﬁcant results (Table 3), suggesting a
selective publication of statistically signiﬁcant ﬁndings.
Analysis of Abide
Behavioral Characteristics. Scores in the Autism Diag-
nostic Observation Schedule (ADOS) were available for 415
subjects: 95.3% of the patients had scores $7, a threshold
suggestive of ASD; 70.5% had scores $10, suggestive of the
most classic autism phenotype. Several sites provided indi-
vidually calibrated severity ADOS scores (15): 81.7% of the
patients had scores $6, suggestive of ASD. There wereFigure 2. Standardized mean dif-
ference in corpus callosum size
between patients with autism spec-
trum disorders and control subjects in
the articles analyzed. The standar-
dized effect sizes (mean differences)
were not found to be heterogeneous,
and the ﬁxed and random effects
meta-analyses provided the same
estimates of the mean effect size,
2.51 (95% conﬁdence interval 5
2.63 to 2.38, Z 5 27.642, p ,
.0001). For each study, the size of
the square corresponds with the sam-
ple size. The standardized mean dif-
ference is shown by diamonds (the
estimation was the same for the ﬁxed
and random effects models).
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Figure 3. Standard error versus standard mean difference. The funnel
plot does not show a bias among articles with small sample sizes (large
standard errors) to overestimate the standard mean difference. However,
the absence of studies with sufﬁciently large cohorts does not allow us to
conclude an absence of publication bias. The dashed lines indicate the
95% conﬁdence interval.
Table 4. Site, Age, Sex, and Group Effects in ICV, BV, and CC
ICV BV CC
Mean Size (cm3) 6 SD 1368 6 231 1131 6 130 3.16 6 .54
Site Effect
F 32.8 10.6 10.7
p value ,.0001 ,.0001 ,.0001
R2 43.7% 20.1% 20.2%
Age Effect
Increase (cm3/year) 4.3 2.3 .019
F 12.19 10.86 45
p value .0005 .001 ,.0001
R2 1.7% 1.5% 6.1%
Sex Effect
Percent difference
(1-female/male)
9.4% 9.3% 7.4%
F 28.2 62.11 17.1
p value ,.0001 ,.0001 ,.0001
R2 3.9% 8.2% 2.4%
Group Effect
Difference (cm3) 6.8 4 2.007
F .26 .03 .35
p value .61 .86 .56
R2 .00 .00 .00
Variance Explained by
the Full Model
46.9% 26.0% 22.0%
BV, total brain volume; CC, corpus callosum; ICV, intracranial
volume.
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and control subjects in the Social Responsiveness Scale (p ,
.0001) and Autism Quotient scores (p , .0001). Abide includes
only high-functioning subjects. FIQ was statistically signiﬁ-
cantly lower among patients (6 points, p , .0001), mostly due
to a statistically signiﬁcantly lower VIQ (8 points, p , .001).
There was no statistically signiﬁcant difference in PIQ (p 5
.19). VIQ and PIQ were correlated at ρ 5 .44 (for further details
on autistic traits and intelligence scores, see Supplemental
Materials, Table S1, and Figure S3 in Supplement 1).
Neuroanatomical Diversity: Differences Related to
Age, Sex, Scanning Site, and Diagnostic Group. There
were signiﬁcant effects of age, sex, and scanning site on CC,
BV, and intracranial volume (ICV), but no statistically signiﬁ-
cant differences were related to diagnostic group (Table 4;
Table S2 in Supplement 1). Subcallosal regions were not
statistically signiﬁcantly different either (Tables S3 and S4 in
Supplement 1). Including subjects with mislabeled fornix did
not change our results (Table S9 in Supplement 1). Total CC
volume presented a small correlation with ICV (ρ 5 .27) and a
medium correlation with BV (ρ 5 .43). The same was observed
for individual callosal regions (Table S5 in Supplement 1).
Indeed, the variability of callosal region size was strongly
related to total CC size: the ﬁrst principal component of the
variance-covariance matrix of callosal region size captured
65% of the variance and correlated with ρ 5 .98 with total CC.
A partial correlation analysis suggested that the variability of
the CC was more directly related to BV than to ICV and that
the observed correlation between ICV and CC was largely
mediated by BV (Table S6 in Supplement 1). In consequence,
our further analyses related CC variability with BV.
The size of many brain structures changes nonlinearly
relative to total BV; for example, large brains tend to have
disproportionately more cortical surface area than small brains
(16,17). We estimated the way in which the proportion of
region Y changes relative to region X by the slope β of the
regression of log(Y) on log(X), known as the scaling coefﬁcient.
If β is 1, the volume of Y is proportional to the volume of130 Biological Psychiatry July 15, 2015; 78:126–134 www.sobp.org/joX (called isometry); if β , 1, the proportion of Y decreases as
X increases (negative allometry); and if β .1, the proportion of
Y is progressively larger as X increases (positive allometry).
There was a statistically signiﬁcant negative allometry of CC
with BV, with scaling coefﬁcient β = .64 (95% conﬁdence
interval = .54–.75), i.e., the proportion of CC in large brains
should be smaller than in small brains (Figure 4; Figure S4 in
Supplement 1). Including subjects with mislabeled fornix did
not change our results (β 5 .71, 95% conﬁdence interval 5
.62–.79). We observed the same negative scaling for each
callosal subregion (average β 5 .64, range from .58 to .73;
Table S7 in Supplement 1). The scaling coefﬁcient for CC was
not different between patients with ASD and control subjects
—neither the diagnostic group effect nor the interaction
between diagnostic group and BV were statistically signiﬁcant
(diagnostic group: p 5 .43, F 5 .62; diagnostic group 3 BV:
p 5 .85, F 5 .04). Additionally, none of the callosal regions
showed signiﬁcant differences between patients and control
subjects. Because of the negative allometry between CC and
BV and due to the signiﬁcant effect of sex on BV, we expected
female subjects to have smaller CC than male subjects in
absolute terms but larger than male subjects in relative terms
(i.e., CC/BV). This was indeed the case: relative CC was
statistically signiﬁcantly larger in female than male subjects
(age and site as covariates, sex effect: p 5 .0095, F 5 6.75).
The difference was, however, completely explained by the
relationship between CC and BV: adding BV as a covariate
made the sex effect not statistically signiﬁcant (p 5 .18, F 5
1.8), as it had been previously pointed out by Luders et al. (18).urnal
Figure 4. Relationship between corpus callosum (CC) size and total brain
volume (BV). CC volume versus BV volume in logarithmic scale. The CC
volume is proportionally smaller in large brains compared with small brains.
The dashed line has a slope of 1, which would indicate a linear scaling of
CC and BV. The solid line, showing the observed regression line, has a
slope of .64, signiﬁcantly smaller (95% conﬁdence interval 5 .54–.75). ASD,
autism spectrum disorders.
Figure 5. Relationship between full IQ (FIQ) and total brain volume (BV) in
patients with autism spectrum disorders (ASD) and control subjects. The
correlation between FIQ and BV was signiﬁcantly weaker in ASD compared
with control subjects (diagnostic group 3 BV interaction p 5 .0178).
Whereas in control subjects FIQ increased on average by 1 point every 31
cm3, the same 1 point increase in FIQ required an increase of 84 cm3 in
patients with ASD.
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match patient and control groups (8/17 articles in our meta-
analysis used IQ matching). However, IQ and ICV or IQ and BV
are correlated in the general population and matching subject
groups by IQ may also affect the neuroanatomical composi-
tion of the groups. IQ appears to be sensitive also to environ-
mental factors such as stress or socioeconomic status (19). It
was not clear then that the relationship between IQ and brain
size would be the same in a control group and a group of
patients with ASD. Indeed, whereas we did observe the
expected correlation between IQ and BV in the control group
(ρ 5 .23, p , .0001, F 5 18.75), the relationship was
signiﬁcantly weaker in the group of patients with ASD (ρ 5
.04, p 5 .044, F 5 4.10). For equivalent BV, FIQ was lower in
the patient group, and increases in BV resulted in smaller
increases in FIQ in patients compared with control subjects
(diagnostic group effect: p , .0001, F 5 29.33; diagnostic
group 3 BV interaction: p 5 .0178, F 5 5.64; linear model for
FIQ with site, age, and sex covariates and BV, diagnostic
group, and diagnostic group 3 BV as main effects). Whereas
in control subjects FIQ increased on average by 1 point every
31 cm3, the same increase required 84 cm3 in patients
(Figure 5). Including subjects with mislabeled fornix did not
change our results (diagnostic group 3 BV interaction: p 5
.0016 for FIQ).
Most of the difference in the increase of FIQ with BV
between patients and control subjects was due to a difference
in the correlation between VIQ and BV but not between PIQ
and BV. VIQ and BV correlated with ρ 5 .22 in control subjects
but with ρ 5 .08 in patients. By contrast, PIQ and BV
correlated with ρ 5 .18 and ρ 5 .17 in control subjects andBiologicalpatients, respectively (Table S8 in Supplement 1 shows
correlations at individual sites). The difference in the increase
of VIQ with BV was statistically signiﬁcant (diagnostic group 3
BV: p 5 .035, F 5 4.5), but the difference in the increase of PIQ
with BV was not statistically signiﬁcant (diagnostic group 3
BV: p 5 .60, F 5 .27). The results were similar if subjects with
mislabeled fornix were included (diagnostic group 3 BV: p 5
.015 for VIQ, p 5 .19 for PIQ).
Simulations: Effect of BV Normalization and IQ
Matching on Diagnostic Group Comparisons
Total BV Normalization. Since the ﬁrst observations by
Kanner (20), many researchers have reported a higher inci-
dence of macrocephaly (21) in ASD, as well as a larger average
BV (22). Recent studies, however, have shed some doubts on
this hypothesis (23,24). In any case, if head circumference or
BV were larger among patients compared with the general
population and because of the negative allometry between CC
and BV, we would expect the proportion of the CC to be
smaller in the ASD group than in the control group.
A frequent strategy for controlling BV effects is to divide CC
by BV (5 of 17 articles in our meta-analysis used it). Our
simulations showed that BV normalization did not eliminate
the effect of a difference in BV between groups when this
difference was large enough (Supplemental Materials and
Figure S5 in Supplement 1). For example, BV normalization
in a study comparing two groups of 50 subjects each with a
mean BV difference of .65 standard deviations should detect a
statistically signiﬁcant difference in CC size 50% of the time. A
mean BV difference of .25 standard deviations should sufﬁcePsychiatry July 15, 2015; 78:126–134 www.sobp.org/journal 131
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[higher than the average statistical power of many neuro-
imaging studies (25)].
Total BV Covariation. An alternative strategy to control for
BV effects is to include BV and diagnostic group 3 BV as
covariates in a linear model (8 of 17 articles in our meta-
analysis used it). Our simulations showed that this approach
controlled better the effect of BV differences between groups,
inducing detectable differences in CC size only for very large
groups and very large differences in BV (Supplemental
Materials and Figure S6 in Supplement 1).
IQ Matching. Intelligence scores are often used to match
patients and control subjects (9 of 17 studies in our meta-
analysis used it). Our analysis of Abide suggested, however,
that IQ and brain size were correlated differently in patients
and control subjects. If larger increases in BV were required
among patients than control subjects to obtain similar
increases in IQ, matching groups by IQ may bias the recruit-
ment to either decrease the number of control subjects with
large BV or increase the number of patients with large BV. This
bias could, in turn, affect the assessment of group differences
in CC size. We simulated the impact of matching by FIQ two
groups with different correlations between FIQ and BV
(Supplemental Materials in Supplement 1). The results
(Figure S7 in Supplement 1) showed that only in groups with
a strong relationship between IQ and BV did the strategy of
matching groups by FIQ induce a reproducible artefactual
difference in mean BV. For example, comparisons between
two groups of 50 subjects, each with a correlation between IQ
and BV or ρIB 5 .5, will detect a signiﬁcant difference in BV
20% of the time.DISCUSSION
Despite recurrent reports of smaller CC in ASD compared with
control subjects, our analyses of Abide did not show any
statistically signiﬁcant difference. The difference that we
observed was ,.02 standard deviations for CC size and
,.04 standard deviations for BV—practically inexistent. This
contrasts starkly with the global effect size found in our meta-
analysis: .5 standard deviations, more than 20 times larger.
Studies using small cohorts can produce statistically signiﬁ-
cant results only if the effect sizes are large. Combined with a
selective report of positive ﬁndings, this makes meta-analyses
based on small studies tend to overestimate the true effect
size (26).
The absence of difference does not seem to be due to a
difference in the characteristics of Abide. Abide was compa-
rable with the cohorts described in the literature in regard to
the subjects’ age, sex ratio, and IQ level. Additionally, patients
with ASD in Abide do not seem to present with a milder
autistic phenotype: ADOS, Autism Quotient, and Social
Responsiveness Scale scores were all highly signiﬁcantly
different between patients and control subjects. Several of
the previous reports, however, included low-functioning sub-
jects either exclusively or in addition to high-functioning
subjects, whereas Abide includes only high-functioning132 Biological Psychiatry July 15, 2015; 78:126–134 www.sobp.org/josubjects. But differences in CC size had been equally reported
among low-functioning and high-functioning subjects. Out of
the nine studies in our meta-analysis that included exclusively
high-functioning subjects, six reported signiﬁcant differences
in CC size as large as .78 standard deviations. High-
functioning subjects represent, however, just one part of the
autistic spectrum. Our results do not rule out the possibility
that differences in CC size could be found in a sufﬁciently
powered analysis of a cohort including subjects with low-
functioning ASD.
The absence of difference does not seem to stem either
from the multi-centric, nonharmonized nature of Abide. Sev-
eral scanning sites within Abide included as many or even
more subjects than in the previous literature (New York
University Langone Medical Center: n 5 129, University of
Utah, School of Medicine: n 5 68, University of California, Los
Angeles: n 5 67). In none of them did we detect a statistically
signiﬁcant difference. Finally, the computational neuroanatomy
methods that we used to segment and measure CC, BV, and
ICV are all standard and well validated. A recent analysis of
Abide by Haar et al. (27) did ﬁnd a small but statistically
signiﬁcant difference in the middle section of the CC; however,
this is a region that was often mislabeled by FreeSurfer (30%
of our cohort). We are making available our data tables and
scripts, as well as a web interface with our quality control
decisions, to allow the community to inspect and criticize our
analyses (http://siphonophore.org/corpuscallosum). The scan-
ning site effect in Abide was strongly signiﬁcant and may have
masked subtle differences. To detect them, future collabora-
tive efforts will required large cohorts and methodological
harmonization.
The major, clear, difference between our analysis and the
previous ones was statistical power: we achieved 99% power
to detect differences of .3 standard deviations, whereas the
highest statistical power to detect this effect size among the
studies in our meta-analysis was only 36%. Given the low
statistical power of the previous reports, even if there were a
real difference in CC of this size, there should be 80% of
negative reports. However, only 8 of the 17 articles analyzed
reported nonsigniﬁcant differences. The scarcity of negative
results is especially marked in autism research (28), a very
damaging tendency that impedes us from deciding on which
hypotheses are worth pursuing: our meta-analysis was well
powered to detect even small differences; however, selective
publication makes the results uninterpretable.
Despite the appeal of the hypothesis of a smaller CC in
ASD, we need to consider the possibility that it may not be
true. Does this falsify or weaken the underconnectivity theory?
The underconnectivity theory states that autism is caused by
insufﬁcient integration circuitry (3). But whereas many articles
in different subﬁelds of autism research have indicated that
their ﬁndings support (verify) the underconnectivity hypothesis,
it is not clear what ﬁnding would be necessary to prove it
wrong (falsify it). As pointed out by Braitenberg (29), most of
the brain tissue could be considered as circuitry (myelinated
and nonmyelinated axons, dendrites), the main role of which is
undoubtedly some type of integration. It is not entirely
surprising that autism, as other psychiatric disorders, can be
interpreted as some type of insufﬁciency in integration circui-
try. We believe that to progress, autism research requires aurnal
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Psychiatrytheoretical framework with stronger, more clearly falsiﬁable
predictions. In particular, a smaller CC has not been directly
stated as a prediction of the underconnectivity theory. If our
aim were to preserve the theory, we could simply add an ad
hoc clause (autism is caused by an insufﬁciency in integration
circuitry of a type that does not change the size of the corpus
callosum), but the appropriateness of this approach has been
criticized (30).
Our results suggest that nonlinear variations in CC size
relative to BV present in the general population or different
patterns of covariation of confounding factors could lead to
some of the group differences reported in the literature. We
found that 19% of the variance in CC size was captured by a
relationship with BV, where progressively larger brains had a
proportionally smaller CC. If for some reason BV in one
population were different than in the other, this could lead to
a group difference in CC size (for example, if female and male
subjects were compared). Our analyses showed that normal-
ization of CC by BV (which supposed isometric scaling) is
insufﬁcient to control for differences in BV. Including BV as a
covariate provides a more reliable control and should be
preferred to normalization. Besides a real difference in BV,
we showed that IQ matching could, under certain circum-
stances, induce an artifactual BV difference that could be later
observed as a CC size difference. Finally, besides the allo-
metric scaling of CC and BV, similar nonlinear relationships
have been also observed between total cortical surface and
BV, between folding and BV, and between white matter
volume and BV. Because of these nonlinear scaling relation-
ships, it is expected that subjects with larger BV will have a
larger cortical surface area, more folded particularly in the
prefrontal cortex (16), and with a larger frontal white matter
volume (17). These are exactly the ﬁndings that have been
reported in several articles comparing patients with ASD and
control subjects (3,31–33). The extent to which they arise from
a difference in BV (real or artifactual) has yet to be evaluated.
We found that intelligence scores do not covary with BV in
the same way in ASD and control subjects. This is not
completely surprising, as FIQ—and VIQ in particular—are
known to be affected by environmental factors such as stress
or socioeconomic status (19). Psychiatric disorders such as
ASD do not only impose to the patients the cognitive
challenges that we most often use to deﬁne them but also a
daily confrontation with various comorbidities and various
degrees of social, educational, and daily life difﬁculties
depending on our society’s ability to integrate them. This
additional burden is very likely to leave physiological traces, in
particular neuroanatomical. Finding the biological markers of
the causes of ASD may then require us to disentangle them
not only from risk factors but also from the social effects of
being different (handicap, disadvantage, etc.).
Research suggests today that the etiology of ASD is highly
heterogeneous, with hundreds of genetic mutations associ-
ated with it (34,35), as well as many environmental factors. The
patient’s phenotypes are also so diverse, with the presence of
such large numbers of different comorbidities and wide
spectrum of cognitive abilities, that one could wonder about
the relevance of looking for neuroanatomical traits common to
all of them. It is important, however, to remember that the
nervous system is strongly self-regulated and capable ofBiologicalstriking plasticity: the processes leading to the formation of
a mammalian nervous system are very resilient and able to
produce viable cognitive function under the most extreme
circumstances. The phenomena that we may be able to
observe at the scale of the complete nervous system will be
more likely the trace of this shared mechanism of develop-
mental canalization and compensation than a direct reﬂection
of the heterogeneous etiology. In this sense, the comprehen-
sion of the normal response of the nervous system to
perturbation and the way in which the diversity of this
response is regulated by the complete individual’s genetic
background may turn out to be as important as the direct
study of the pathologic cause. The study of large cohorts with
extensive behavioral, genetic, and neuroimaging data will be of
fundamental relevance for this objective.ACKNOWLEDGMENTS AND DISCLOSURES
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